Natera, Inc. (NTRA)
NASDAQ
Healthcare
Medical - Diagnostics & Research
$221.29
▼ -0.93%
Market Cap
$31.69B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.57
52-Wk Range
131.811-256.36
CEO
Steven Leonard Chapman
Country
US
Currency
USD
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora …
Open full interactive analysis & DCF →